Literature DB >> 13906393

The thrombotic activity of activation product.

E S HENDERSON, S L RAPAPORT.   

Abstract

Keywords:  BLOOD COAGULATION; THOROMBOSIS

Mesh：

Year:  1962        PMID： 13906393      PMCID： PMC289218          DOI： 10.1172/JCI104475

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  Clearance of blood coagulation product I in rabbits.

Authors:  T H SPAET; J CINTRON
Journal:  Proc Soc Exp Biol Med       Date:  1960-07

2.  Biologic assay of a thrombosis-inducing activity in human serum.

Authors:  S WESSLER; S M REIMER; M C SHEPS
Journal:  J Appl Physiol       Date:  1959-11       Impact factor: 3.531

3.  A simple, specific one-stage assay for plasma thromboplastin antecedent activity.

Authors:  S I RAPAPORT; S SCHIFFMAN; M J PATCH; A G WARE
Journal:  J Lab Clin Med       Date:  1961-05

4.  A one stage method for the assay of antihemophilic factor B (AHF B) with a comment on the antihemophilic factor B (AHF B) concentration in phenylindanedione (PID) therapy.

Authors:  W F STAPP
Journal:  Scand J Clin Lab Invest       Date:  1958       Impact factor: 1.713

5.  Possible relationships between clotting factors in vitro and intravascular clotting.

Authors:  S I RAPAPORT
Journal:  Angiology       Date:  1959-10       Impact factor: 3.619

6.  Factor VII; its turnover rate and its possible role in thrombogenesis.

Authors:  E A LOELIGER; C ter HAAR; H L BOOIJ
Journal:  Thromb Diath Haemorrh       Date:  1960-03-01

7.  The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin.

Authors:  H STORMORKEN
Journal:  Scand J Clin Lab Invest       Date:  1957       Impact factor: 1.713

8.  The effect of glass upon the activity of the various plasma clotting factors.

Authors:  S I RAPAPORT; K AAS; P A OWREN
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

9.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

10.  Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma.

Authors:  S SCHIFFMAN; S I RAPAPORT; A G WARE; J W MEHL
Journal:  Proc Soc Exp Biol Med       Date:  1960-12
View more
  8 in total

1.  ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.

Authors:  D DEYKIN; S WESSLER
Journal:  J Clin Invest       Date:  1964-02       Impact factor: 14.808

2.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

3.  THE ROLE OF LIPOPROTEINS IN THE PRODUCTION OF HYPERCOAGULABILITY: A NEW CONCEPT.

Authors:  R M HOWELL; G B SCOTT
Journal:  Br J Exp Pathol       Date:  1964-12

4.  Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients.

Authors:  K M Simpson; D L Bunch; H Amemiya; H J Boehmig; C B Wilson; F J Dixon; A J Coburg; W E Hathaway; G R Giles; T E Starzl
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

5.  Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection.

Authors:  T E Starzl; H J Boehmig; H Amemiya; C B Wilson; F J Dixon; G R Giles; K M Simpson; C G Halgrimson
Journal:  N Engl J Med       Date:  1970-08-20       Impact factor: 91.245

6.  Activation of factors XII and XI in thrombogenesis.

Authors:  H L Nossel
Journal:  Bull N Y Acad Med       Date:  1972-02

7.  Intravascular coagulation secondary to cavernous hemangioma in infancy: response to radiotherapy.

Authors:  A Pyesmany; H Ekert; K Williams; R Hittle
Journal:  Can Med Assoc J       Date:  1969-06-14       Impact factor: 8.262

8.  Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements.

Authors:  H J Boehmig; G R Giles; H Amemiya; C B Wilson; A J Coburg; E Genton; D L Bunch; F J Dixon; T E Starzl
Journal:  Transplant Proc       Date:  1971-06       Impact factor: 1.066
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.